65
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Development of ocular hypertension and persistent glaucoma after intravitreal injection of triamcinolone

, , , &
Pages 167-171 | Published online: 07 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Abdourahman Cham, Mayank Bansal, Himanshu K Banda, Young Kwon, Paul S Tlucek, Alexander G Bassuk, Stephen H Tsang, Warren M Sobol, James C Folk, Steven Yeh & Vinit B Mahajan. (2016) Secondary glaucoma in CAPN5-associated neovascular inflammatory vitreoretinopathy. Clinical Ophthalmology 10, pages 1187-1197.
Read now
Joseph F Griffith & Jeffrey L Goldberg. (2015) Prevalence of comorbid retinal disease in patients with glaucoma at an academic medical center. Clinical Ophthalmology 9, pages 1275-1284.
Read now
Yalong Dang, Yalin Mu, Lin Li, Yahui Mu, Shujing Liu, Chun Zhang, Yu Zhu & Yimin Xu. (2014) Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients. Drug Design, Development and Therapy 8, pages 1441-1449.
Read now
Hui-Ping Qi, Sheng Bi, Shu-Qin Wei, Hao Cui & Jing-Bo Zhao. (2012) Intravitreal Versus Subtenon Triamcinolone Acetonide Injection for Diabetic Macular Edema: A Systematic Review and Meta-analysis. Current Eye Research 37:12, pages 1136-1147.
Read now
Pier E Gallenga & Lucio Lobefalo. (2008) Patients treated with intravitreal triamcinolone acetonide. Clinical Ophthalmology 2:2, pages 483-483.
Read now
Scott G Fraser. (2008) Looking forward to another exciting year of Clinical Ophthalmology. Clinical Ophthalmology 2:1, pages i-ii.
Read now

Articles from other publishers (8)

Yohei Tomita, Deokho Lee, Kazuo Tsubota, Kazuno Negishi & Toshihide Kurihara. (2021) Updates on the Current Treatments for Diabetic Retinopathy and Possibility of Future Oral Therapy. Journal of Clinical Medicine 10:20, pages 4666.
Crossref
Josh O. Wallsh & Ron P. Gallemore. (2021) Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options. Cells 10:5, pages 1049.
Crossref
Anne‐Eva Wijk, Paul Canning, Rutger P. Heijningen, Ilse M.C. Vogels, Cornelis J.F. Noorden, Ingeborg Klaassen & Reinier O. Schlingemann. (2018) Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood–retinal barrier . Acta Ophthalmologica 97:2, pages 214-224.
Crossref
Refika Hande KARAKAHYA, Defne KALAYCI & Ahmet KARAKURT. (2018) Ocular Hypertension and Glaucoma after Intravitreal Injection of Triamcinolone Acetonide. Middle Black Sea Journal of Health Science 4:1, pages 24-30.
Crossref
JyotiHimanshu Matalia, VimalKrishna Rajput, Himanshu Matalia & BhujangK Shetty. (2018) Endoilluminator-assisted pediatric cataract surgery with hazy cornea. Indian Journal of Ophthalmology 66:8, pages 1198.
Crossref
Andrew A. ChangHaitao LiGeoffrey K. BroadheadKehui LuoMeidong Zhu. (2015) Safety and Efficacy of Intravitreal Preservative-Free Triamcinolone Acetonide (Triesence) for Macular Edema. Journal of Ocular Pharmacology and Therapeutics 31:9, pages 563-569.
Crossref
Dongwook Kim, Woo Ho Nam, Ha Kyoung Kim & Kayoung Yi. (2014) Does Intravitreal Injections of Bevacizumab for Age-related Macular Degeneration Affect Long-term Intraocular Pressure?. Journal of Glaucoma 23:7, pages 446-448.
Crossref
Weerawat Kiddee, Graham E. Trope, Lisa Sheng, Laura Beltran-Agullo, Michael Smith, M. Hermina Strungaru, Jasrajbir Baath & Yvonne M. Buys. (2013) Intraocular Pressure Monitoring Post Intravitreal Steroids: A Systematic Review. Survey of Ophthalmology 58:4, pages 291-310.
Crossref